Yaqing Shu

7PUBLICATIONS
5CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Optical technologyAutonomic nervous systemCardiovascular medicine and haematology not elsewhere classifiedCentral nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 31, 2022
Immunosuppressant and neuromyelitis optica spectrum disorder: optimal treatment duration and risk of discontinuation.

Rui Li, Cong Li, Qiao Huang

|Mar 30, 2021
Optical coherence tomography angiography helps distinguish multiple sclerosis from AQP4-IgG-seropositive neuromyelitis optica spectrum disorder.

Chunxin Liu, Hui Xiao, Xiayin Zhang

|Oct 16, 2020
Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is associated with IRF7, BANK1 and TBX21 polymorphisms in two populations.

Y Shu, J Guo, X Ma

|Apr 20, 2018
Characteristics of paramedian pontine arteries disease and its association with hemoglobinA1c.

Haiyan Li, Yaqing Shu, Biao Hu

|Apr 01, 2018
Association of serum Cystatin C with neuromyelitis optica spectrum disorders.

Y Shu, L Zhang, Y Chang

|Jan 10, 2018
Serum cystatin C and anti-N-methyl-D-aspartate receptor encephalitis.

Y Shu, Y Chang, H Wu

Pageof 2

Frequent Collaborators

3 joint publications

Wei Qiu

2 joint publications

Yanyu Chang

2 joint publications

Zhengqi Lu

1 joint publications

H Wang